Skip to content

A clinical trial to evaluate the effect of Panchakarma(basti) in treating knee joint pain.

Evaluation of kala basti protocol with Patoladi-ksheera niruha basti and ksheerabala thaila anuvasana basti in Osteoporosis

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/09/027735
Enrollment
10
Registered
2020-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M818- Other osteoporosis without currentpathological fracture

Interventions

Intervention1: Patoladi-ksheera niruha basti and Ksheerabala thaila anuvasana basti.: Every day local abhyanga will be done with murchita tila taila followed by nadi sweda,later to this subject will b

Sponsors

KLE University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients between the age group of 35-65 years of either sex. 2.Patients of Osteoporosis diagnosed by B.M.D test (t-score-2.5 and below). 3.Patients complaining of classical symptoms of Asthikshaya like joint pain, pain in the bones etc. 4.Patient fit for Basti Karma.

Exclusion criteria

Exclusion criteria: 1.Patients with endocrine disorders (Hyperthyroidism,hyperparathyroidism, Untreated Cushing syndrome) 2.Patients suffering from pathological Osteoporosis and neoplasms of the bone. 3.Patients suffering from chronic hepatic disorder, renal failure or cardiac dysfunction. 4.Patients suffering from Mal-absorption syndrome. 5.Patients undergone Organ transplantation or on immunosuppressive therapy. 6.Patients with clinical evidence of active and chronic illness as rheumatoid arthritis, gout , SLE, Psoriatic arthritis.

Design outcomes

Primary

MeasureTime frame
1)REDUCTION IN PAIN- Assessed using Visual analogue scale and using grading for tenderness 2)REDUCED GENERAL DEBILITY- assessed using grading for general debility 3)Changes in serum calcium and alkaline phosphataseTimepoint: 16th and 48th day

Secondary

MeasureTime frame
improved quality of life in patients with osteoporosis assessed by Medical Outcomes Survey 36-item short form questionnaire (SF-36)Timepoint: 48th day

Countries

India

Contacts

Public ContactDr Pradeep L Grampurohit

KAHERS Shri B M Kankanawadi Ayurveda Mahavidyalaya

pradeepgrampurohit@gmail.com9964144197

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026